Go Pro

Teleflex (TFX) Competitors

Teleflex logo
$124.49 -1.10 (-0.88%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$124.70 +0.21 (+0.17%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TFX vs. STE, ZBH, PEN, BAX, and SNN

Should you buy Teleflex stock or one of its competitors? Teleflex's main competitors and comparable companies include STERIS (STE), Zimmer Biomet (ZBH), Penumbra (PEN), Baxter International (BAX), and Smith & Nephew SNATS (SNN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Teleflex compare to STERIS?

Teleflex (NYSE:TFX) and STERIS (NYSE:STE) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B2.65-$905.64M-$23.29N/A
STERIS$5.94B3.37$782.30M$8.1825.08

Teleflex presently has a consensus target price of $152.90, indicating a potential upside of 22.82%. STERIS has a consensus target price of $271.33, indicating a potential upside of 32.27%. Given STERIS's stronger consensus rating and higher possible upside, analysts plainly believe STERIS is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42
STERIS
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

STERIS has a net margin of 13.34% compared to Teleflex's net margin of -39.67%. STERIS's return on equity of 14.34% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
STERIS 13.34%14.34%9.66%

95.6% of Teleflex shares are held by institutional investors. Comparatively, 94.7% of STERIS shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 1.1% of STERIS shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, STERIS had 1 more articles in the media than Teleflex. MarketBeat recorded 5 mentions for STERIS and 4 mentions for Teleflex. Teleflex's average media sentiment score of 1.37 beat STERIS's score of 0.70 indicating that Teleflex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
STERIS
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, STERIS has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. STERIS pays an annual dividend of $2.76 per share and has a dividend yield of 1.3%. Teleflex pays out -5.8% of its earnings in the form of a dividend. STERIS pays out 33.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has increased its dividend for 20 consecutive years. STERIS is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

STERIS beats Teleflex on 15 of the 20 factors compared between the two stocks.

How does Teleflex compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Zimmer Biomet has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.0%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Zimmer Biomet pays out 23.4% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Zimmer Biomet currently has a consensus price target of $103.00, suggesting a potential upside of 7.93%. Teleflex has a consensus price target of $152.90, suggesting a potential upside of 22.82%. Given Teleflex's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Zimmer Biomet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet
2 Sell rating(s)
14 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.18
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

Zimmer Biomet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zimmer Biomet$8.23B2.21$705.20M$4.1123.22
Teleflex$1.99B2.65-$905.64M-$23.29N/A

Zimmer Biomet has a net margin of 9.48% compared to Teleflex's net margin of -39.67%. Zimmer Biomet's return on equity of 13.12% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Zimmer Biomet9.48% 13.12% 7.23%
Teleflex -39.67%11.93%5.44%

In the previous week, Zimmer Biomet had 2 more articles in the media than Teleflex. MarketBeat recorded 6 mentions for Zimmer Biomet and 4 mentions for Teleflex. Teleflex's average media sentiment score of 1.37 beat Zimmer Biomet's score of 0.66 indicating that Teleflex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zimmer Biomet
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 1.3% of Zimmer Biomet shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Zimmer Biomet beats Teleflex on 10 of the 19 factors compared between the two stocks.

How does Teleflex compare to Penumbra?

Teleflex (NYSE:TFX) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 2.9% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Penumbra has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B2.65-$905.64M-$23.29N/A
Penumbra$1.40B8.91$177.69M$4.0778.04

Teleflex has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

Penumbra has a net margin of 10.67% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
Penumbra 10.67%10.50%8.17%

In the previous week, Teleflex and Teleflex both had 4 articles in the media. Teleflex's average media sentiment score of 1.37 beat Penumbra's score of 0.87 indicating that Teleflex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Penumbra
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teleflex currently has a consensus price target of $152.90, suggesting a potential upside of 22.82%. Penumbra has a consensus price target of $367.07, suggesting a potential upside of 15.57%. Given Teleflex's stronger consensus rating and higher possible upside, equities analysts plainly believe Teleflex is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42
Penumbra
0 Sell rating(s)
14 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18

Summary

Teleflex beats Penumbra on 9 of the 16 factors compared between the two stocks.

How does Teleflex compare to Baxter International?

Baxter International (NYSE:BAX) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Teleflex had 2 more articles in the media than Baxter International. MarketBeat recorded 4 mentions for Teleflex and 2 mentions for Baxter International. Teleflex's average media sentiment score of 1.37 beat Baxter International's score of 0.92 indicating that Teleflex is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International has a net margin of -9.27% compared to Teleflex's net margin of -39.67%. Baxter International's return on equity of 16.57% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-9.27% 16.57% 5.24%
Teleflex -39.67%11.93%5.44%

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Baxter International pays out -1.9% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Baxter International presently has a consensus target price of $22.45, suggesting a potential downside of 1.49%. Teleflex has a consensus target price of $152.90, suggesting a potential upside of 22.82%. Given Teleflex's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
2 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

Baxter International has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Teleflex has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$11.24B1.05-$957M-$2.07N/A
Teleflex$1.99B2.65-$905.64M-$23.29N/A

Summary

Teleflex beats Baxter International on 15 of the 19 factors compared between the two stocks.

How does Teleflex compare to Smith & Nephew SNATS?

Teleflex (NYSE:TFX) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Smith & Nephew SNATS has a net margin of 0.00% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
Smith & Nephew SNATS N/A N/A N/A

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Smith & Nephew SNATS has higher revenue and earnings than Teleflex.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B2.65-$905.64M-$23.29N/A
Smith & Nephew SNATS$6.16B1.88$625MN/AN/A

Teleflex has a beta of 0.82, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market.

Teleflex presently has a consensus price target of $152.90, suggesting a potential upside of 22.82%. Smith & Nephew SNATS has a consensus price target of $31.91, suggesting a potential upside of 15.77%. Given Teleflex's stronger consensus rating and higher probable upside, equities analysts plainly believe Teleflex is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42
Smith & Nephew SNATS
1 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.4%. Teleflex pays out -5.8% of its earnings in the form of a dividend.

In the previous week, Teleflex had 2 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 4 mentions for Teleflex and 2 mentions for Smith & Nephew SNATS. Teleflex's average media sentiment score of 1.37 beat Smith & Nephew SNATS's score of 0.66 indicating that Teleflex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Teleflex beats Smith & Nephew SNATS on 12 of the 17 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Sign up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TFX vs. The Competition

MetricTeleflexHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$5.28B$5.57B$7.24B$23.10B
Dividend Yield1.09%1.80%2.57%3.62%
P/E Ratio-5.3525.34275.4928.21
Price / Sales2.6543.73639.6320.30
Price / Cash11.1332.6476.2536.36
Price / Book1.765.6910.464.67
Net Income-$905.64M$151.55M$3.49B$1.07B
7 Day Performance-4.86%0.66%0.59%-1.64%
1 Month Performance-7.92%-3.33%-1.74%-3.60%
1 Year Performance1.51%6.79%18.13%8.41%

Teleflex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TFX
Teleflex
4.7922 of 5 stars
$124.49
-0.9%
$152.90
+22.8%
+1.5%$5.28B$1.99BN/A15,500
STE
STERIS
4.7655 of 5 stars
$211.10
-0.6%
$271.33
+28.5%
-17.5%$20.55B$5.94B25.8117,937
ZBH
Zimmer Biomet
3.6843 of 5 stars
$93.47
+1.1%
$104.42
+11.7%
-4.6%$17.83B$8.23B22.7417,000
PEN
Penumbra
3.5335 of 5 stars
$317.86
+0.0%
$367.07
+15.5%
+24.1%$12.52B$1.50B78.104,700
BAX
Baxter International
1.332 of 5 stars
$23.81
-1.6%
$22.45
-5.7%
-1.0%$12.30B$11.24BN/A37,500

Related Companies and Tools


This page (NYSE:TFX) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners